IMARC Group, a leading market research company, has recently released a report titled "Tonometer Market Size, Share, Trends and Forecast by Type, Technology, Portability, End User, and Region, 2025-2033." The study provides a detailed analysis of the industry, including the global tonometer market size, share, trends, growth and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Market Overview
The global tonometer market was valued at USD 374.9 Million in 2024 and is expected to reach USD 555.8 Million by 2033. The market is projected to grow at a CAGR of 4.5% during the forecast period from 2025 to 2033. Factors driving growth include rising glaucoma prevalence, advancements in non-contact and rebound tonometers, increasing government vision care programs, and expanding teleophthalmology services.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Tonometer Market Key Takeaways
- Current Market Size: USD 374.9 Million in 2024
- CAGR: 4.5% (2025-2033)
- Forecast Period: 2025-2033
- North America dominates the market with over 39.6% market share in 2024, driven by high glaucoma prevalence and advanced healthcare.
- Technological advances, such as non-contact and rebound tonometers, improve patient comfort and diagnostic accuracy.
- Increasing investments in AI-integrated diagnostic tools enhance early detection and predictive analytics for glaucoma.
- The rise of teleophthalmology and remote eye care services expands market reach, especially in underserved regions.
- Growing geriatric population and government initiatives for preventive eye care further boost demand.
Request Your Free “Tonometer Market” Insights Sample PDF: https://www.imarcgroup.com/tonometer-market/requestsample
Market Growth Factors
Global increase in prevalence of glaucoma and other eye diseases is a major factor for the tonometer market. In North America, high prevalence of glaucoma, advanced healthcare infrastructure and reimbursement policies drive the market. According to the CDC, 3 million Americans have glaucoma. It is one of the leading causes of blindness. Early detection through eye examination and testing, in addition to improved technologies, are driving the market. Government vision care programs, especially in developing countries, are now starting to include tonometers as part of their service.
Non-contact tonometer (air-puff) and rebound tonometers that do not require anesthetic and do not pose a risk of cross-contamination are expected to drive growth. Portable and handheld tonometers are also expected to drive adoption of home, ambulatory, and teleophthalmology care. Artificial intelligence (AI) technology with machine learning algorithms may be used for early glaucoma screening, automated prognostic and diagnostic analytics, and big data predictive analytics, which may be helpful in low- and middle-income countries or remote areas when other equipment is not available.
The major factors that are expected to increase the market growth are the growing investments in the healthcare infrastructure in emerging economies and the increase in the number of specialty ophthalmic clinics. The growing investments in the digital health platforms and teleophthalmology are also expected to increase the market. The increasing elderly population susceptible to eye diseases as well as increasing government initiatives for preventive eye check-ups are expected to drive the tonometers market.
Tonometer Market Segmentation
Breakup By Type:
- Direct
- Indirect
Indirect tonometers dominated the market in 2024, favored for their patient-friendly intraocular pressure (IOP) measurement and reduced corneal damage risk. Particularly, rebound tonometers offer advantages for pediatric and geriatric screenings, improving accuracy and comfort.
Breakup By Technology:
- Applanation Tonometry
- Indentation Tonometry
- Rebound Tonometry
- Others
Applanation tonometry leads with around 51.4% market share in 2024. Known for reliability and accuracy, it remains the gold standard, especially the Goldmann applanation tonometer widely used in clinical settings.
Breakup By Portability:
- Desktop
- Handheld
Handheld devices hold a dominant share (~72.2%) due to portability and convenience, allowing IOP measurements beyond clinics, supporting screening programs, home healthcare, and ambulatory care.
Breakup By End User:
- Hospitals
- Ophthalmic Centers
Ophthalmic centers lead with approximately 62.0% market share in 2024, attributed to their specialized eye-care focus, frequent glaucoma patient screening, and investment in advanced tonometry devices.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America holds the largest share of over 39.6% in 2024. Key drivers include robust healthcare infrastructure, high glaucoma prevalence (about 3 million Americans affected), advanced technology adoption, and a substantial geriatric population prone to ocular diseases. The U.S. market alone accounts for 91.4% of North America's tonometer market, supported by strong regulatory frameworks, rising eye disorder prevalence, expanding insurance coverage, and innovations from leading ophthalmic equipment companies.
Recent Developments News
- January 2025: Keeler launched servicing for Goldmann Applanation Tonometers at its European distribution site in Terrasa, Spain, improving support and maintenance efficiency for EU professionals.
- September 2024: Topcon Healthcare introduced the TRK-3 OMNIA, a 4-in-1 auto kerato-refracto tonometer, in Europe, enhancing clinical efficiency with combined diagnostic functions.
- September 2024: iCare launched the ST500 slit-lamp-mounted tonometer using rebound tonometry and the SmartCradle charging/storage port enabling future digital connectivity.
- June 2024: NIDEK introduced the RS-1 Glauvas Optical Coherence Tomography system optimized for glaucoma and retinal diagnostics.
- February 2024: Topcon Healthcare launched the TRK-3 OMNIA for the Asian market, featuring combined ophthalmic diagnostics and digital connectivity.
- January 2024: DevelopAll Inc. launched the FDA-approved Diaton digital tonometer, measuring intraocular pressure through the eyelid for non-invasive glaucoma screening.
Key Players
- 66 Vision Tech Co. Ltd. (Yuwell-Jiangsu Yuyue Medical Equipment Supply Co. Ltd.)
- AMETEK Inc.
- Canon Inc.
- Haag-Streit Group (Metall Zug AG)
- Keeler Ltd. (Halma plc)
- Kowa American Corporation (Kowa Company Limited)
- Nidek Co. Ltd.
- Revenio Group Oyj
- Rexxam Co. Ltd.
- Tomey Corporation
- Topcon Corporation
- Ziemer Ophthalmic Systems AG
Ask Analyst For Request Customization: https://www.imarcgroup.com/request?type=reportid=4759flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
